Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 10    tags : Therapeutics    save search
Chemomab Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
Published: 2022-03-10 (Crawled : 01:00) - biospace.com/
CMMB | News | $0.7 5.7K twitter stocktwits trandingview |
Manufacturing
 | | O: 8.18% H: 0.0% C: 0.0%
health thc conference therapeutics
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
LCTX | $1.16 -3.33% 340K twitter stocktwits trandingview |
Health Technology
 | | O: -1.76% H: 0.0% C: 0.0%
financial results therapeutics cel report results
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
PSTX | News | $2.04 2.0% 120K twitter stocktwits trandingview |
Health Technology
 | | O: -2.75% H: 2.27% C: -0.85%
financial results pos therapeutics results
Capricor Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
CAPR | $5.1 0.99% 130K twitter stocktwits trandingview |
Health Technology
 | | O: -1.54% H: 0.89% C: -8.04%
financial results therapeutics report results
CymaBay Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 17, 2022
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
CBAY | $32.48 0.03% 8.4M twitter stocktwits trandingview |
Health Technology
 | | O: -1.47% H: 1.79% C: -0.6%
day financial results bay therapeutics report results
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
ONCT | News | $8.6 910 twitter stocktwits trandingview |
Health Technology
 | | O: -2.31% H: 1.18% C: -0.59%
financial results therapeutics results
Design Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
DSGN | $3.815 2.01% 110K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: -1.94% H: 2.79% C: 2.03%
financial results therapeutics report results designation
Astria Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
ATXS | $10.16 -3.61% 110K twitter stocktwits trandingview |
Manufacturing
 | | O: 0.31% H: 8.98% C: 6.09%
financial results therapeutics report results
Aligos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published: 2022-03-10 (Crawled : 22:00) - biospace.com/
ALGS | $0.7931 25K twitter stocktwits trandingview |
Health Technology
 | | O: -1.56% H: 0.79% C: -3.16%
financial results therapeutics report results
Viridian Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Updates
Published: 2022-03-10 (Crawled : 22:00) - biospace.com/
VRDN | $15.29 0.86% 470K twitter stocktwits trandingview |
Health Care and Social Assistan...
 | | O: -1.93% H: 2.75% C: -1.14%
financial results therapeutics report results
Allogene Therapeutics Receives FDA Fast Track Designation for its First Solid Tumor Candidate, ALLO-316 in the Treatment of Renal Cell Carcinoma
Published: 2022-03-10 (Crawled : 18:00) - biospace.com/
ALLO | $3.505 1.3% 290K twitter stocktwits trandingview |
Health Technology
 | | O: -2.72% H: 2.56% C: 1.52%
allo-316 fast track designation treatment fda fast track renal therapeutics cel fda fast track designation cell carcinoma
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Full-Year 2021 Financial Results and Discuss Recent Corporate Highlights
Published: 2022-03-10 (Crawled : 18:00) - biospace.com/
ALDX | News | $3.85 -3.27% 130K twitter stocktwits trandingview |
Health Technology
 | | O: -1.16% H: 0.96% C: -1.17%
financial results conference therapeutics report results
Clarus Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-10 (Crawled : 14:00) - globenewswire.com
CRXT | $0.0475 twitter stocktwits trandingview |
| | O: -6.62% H: 1.45% C: -9.82%
health thc conference therapeutics
Cyclo Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-10 (Crawled : 14:00) - biospace.com/
CYTH | $1.2 220 twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: -5.01% H: 6.21% C: 3.73%
health thc conference therapeutics
Omega Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Outlines Key Corporate Objectives for 2022
Published: 2022-03-10 (Crawled : 13:30) - biospace.com/
OMGA | $2.4 -0.83% 41K twitter stocktwits trandingview |
| | O: 5.62% H: 2.2% C: -3.61%
financial results therapeutics report results
TG Therapeutics Announces Scheduling of Planned Oncologic Drug Advisory Committee Meeting
Published: 2022-03-10 (Crawled : 13:30) - globenewswire.com
TGTX | News | $13.735 -1.82% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: -0.11% H: 4.29% C: 1.81%
drug therapeutics
Seres Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-10 (Crawled : 13:00) - biospace.com/
MCRB | $0.5845 0.05% 1.2M twitter stocktwits trandingview |
Health Technology
 | | O: -0.35% H: 6.13% C: 6.13%
health thc conference therapeutics
Virios Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Thursday, March 17, 2022
Published: 2022-03-10 (Crawled : 13:00) - biospace.com/
VIRI | $0.4499 15K twitter stocktwits trandingview |
Health Technology
 | | O: 4.68% H: 5.59% C: -0.19%
day financial results therapeutics report results
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
Published: 2022-03-10 (Crawled : 13:00) - biospace.com/
TXMD | $1.89 4K twitter stocktwits trandingview |
Health Technology
 | | O: 4.48% H: 3.13% C: -6.54%
financial results therapeutics results
Stoke Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Published: 2022-03-10 (Crawled : 13:00) - biospace.com/
STOK | $11.985 2.88% 210K twitter stocktwits trandingview |
Health Technology
 | | O: 1.82% H: 0.53% C: -0.39%
financial results therapeutics report results
Gainers vs Losers
79% 21%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.0606 68.33% 250M twitter stocktwits trandingview |

NVFY | $3.45 63.51% 20M twitter stocktwits trandingview |
Consumer Durables
CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services
PAPL | $2.07 26.22% 550K twitter stocktwits trandingview |

RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
AULT | $0.3022 24.82% 51M twitter stocktwits trandingview |
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.